Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Australia
(12/week)
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Guatemala
(0/week)
View all
(12/week)
News
United States
(492/week)
Manufacturing
(332/week)
Energy
(271/week)
Technology
(348/week)
Other Energy
(234/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
Astellas
Feb 04, 2021
Astellas expands Top Management, names Percival Barretto-Ko as Chief Business Officer; Yoshitsugu Shitaka as Chief Scientific Officer
Oct 28, 2020
Astellas Receives U.S. FDA Fast Track Designation for ASP5354, an Investigational Near-Infrared Fluorescence Imaging Agent
Apr 02, 2020
Astellas Pharma US and Astellas Global Health Foundation COVID-19 Pandemic Response
Mar 31, 2020
Amgen Establishes Wholly-Owned Affiliate In Japan
Feb 10, 2020
Astellas Global Health Foundation and AMPATH Announce a Three-Year $1.35 Million Grant to Aid Mental Health Programming in Western Kenya
Feb 10, 2020
Seattle Genetics and Astellas Announce Updated Results from Phase 1b/2 Trial of PADCEV(TM) (enfortumab vedotin-ejfv) in Combination with Immune Therapy Pembrolizumab as Investigational First-Line Treatment for Advanced Bladder Cancer
Jan 21, 2020
Six Years of Perfect Equality Scores on CEI Index a Testament to Astellas' Culture of Inclusion
Dec 26, 2019
Astellas Strengthens Immuno-oncology Pipeline with Acquisition of Xyphos Biosciences, Inc.
Dec 16, 2019
XTANDI® (enzalutamide) Approved by U.S. FDA for the Treatment of Metastatic Castration-Sensitive Prostate Cancer
Dec 05, 2019
Astellas and MBC BioLabs Announce Golden Ticket Winners - Supporting Biotech Start-Ups to Accelerate Innovative Science
Nov 25, 2019
Astellas Announces the Approval of XTANDI® (enzalutamide) by the China National Medical Products Administration (NMPA)
Oct 10, 2019
Astellas earns spot on Working Mother's Best Companies for Dads List
Sep 28, 2019
Seattle Genetics and Astellas Announce Results from Phase 1 Trial of Investigational Agent Enfortumab Vedotin in Combination with Immune Therapy Pembrolizumab as First-Line Treatment for Advanced Bladder Cancer
Sep 24, 2019
Astellas ranks in Top 10 of Working Mother Best Companies list
Sep 20, 2019
Astellas Receives Positive CHMP Opinion for XOSPATA® (gilteritinib) as a Monotherapy for Patients with Relapsed or Refractory Acute Myeloid Leukemia with a FLT3 Mutation
Sep 18, 2019
Astellas Celebrates Decade of Service by Volunteering 80,000 Hours to Help Local Communities
Sep 11, 2019
Astellas Partners with MBC BioLabs to Help Pioneering Biotech Start-ups Accelerate Early Drug Discovery and Research Efforts
May 09, 2019
Astellas' Chelsea Glinski Named a 2019 Healthcare Businesswomen's Association Luminary
Feb 20, 2019
Astellas and WiserCare Announce Collaboration to Improve Patient Experience
Dec 12, 2018
Astellas Promotes Lei Ding to vice president, Payer Strategy, Contracts, and Pricing
Page 1
››
Latest News
Apr 18, 2024
SkyWater Technology to Announce First Quarter Financial Results on May 8th, 2024
Apr 18, 2024
CF Industries and JERA Announce Joint Development Agreement to Develop Greenfield Low-Carbon Ammonia...
Apr 18, 2024
Mentor Capital Cash Exceeds Share Price and a Second Stock Buyback is Authorized
Apr 18, 2024
WEB Aruba Signs Water-as-a-Service® BOOT Agreement with Seven Seas Water Group
Apr 18, 2024
Aqua Virginia Earns State Excellence Award for 19th Consecutive Year
Apr 18, 2024
Aqua New Jersey Celebrates Completion of Newest PFAS Treatment Facility at its Green Avenue Well Station in...
Apr 18, 2024
Black Stone Minerals, L.P. Declares Distribution for Common Units and Schedules Earnings Call to Discuss...
Apr 18, 2024
HNI Corporation Receives DOE Better Project Award
View all News
Agenda
17
June
France
Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024, 17 - 21 June 2024, Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024 There can be no sustainable world without peace and security. Founded in 1967, the exhibition...
21
May
Paris Marriott Rive Gauche & Conference Center
Future Artillery, 21-23 May 2024, Paris Marriott Rive Gauche & Conference Center, France
DELIVERING FIRES IN THE MULTI-DOMAIN BATTLESPACE As artillery reasserts itself as the ‘King of Battlefield’ in the wake...
21
May
United Arab Emirates
ADNEC (Abu Dhabi National Exhibition Centre), Abu Dhabi, Al Khaleej Al Arabi St - Al Rawdah - Al Ma'arid - Abu Dhabi, UAE
ISNR Abu Dhabi 2024, 21-23 May 2024, ADNEC (Abu Dhabi National Exhibition Centre), Abu Dhabi, Al Khaleej Al Arabi St - Al Rawdah - Al Ma'arid - Abu Dhabi, UAE
ISNR ACCELERATING TRANSFORMATION IN THE NATIONAL SECURITY ECOSYSTEM ISNR Abu Dhabi is the region’s most trusted...
View All Events